Source: International Congress 2018 – New kids on the block: novel molecular pathways and therapeutic targets in chronic lung diseases
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
L. Fang (Basel, Switzerland), M. Tamm (Basel, Switzerland), D. Stolz (Basel, Switzerland), M. Roth (Basel, Switzerland). Supportive interaction of PI3K-Akt-mTOR and STAT3-miR21-PTEN controls IgE induced airway remodeling. 2179

Member's Comments

No comment yet.

Related content which might interest you: A dual role of IL-6 signalling and STAT-3 activation on airway inflammation versus airway hyperresponsiveness in a murine model of asthma Source: Eur Respir J 2002; 20: Suppl. 38, 568s Year: 2002 Inhibition of the alternative complement pathway abolishes the development of airway hyperresponsiveness (AHR) and inflammation Source: Eur Respir J 2004; 24: Suppl. 48, 348s Year: 2004 Inhibition of VEGF blocks the activation of TGF-β1 through a PI3K/Akt signaling pathway in allergic airway disease of mice Source: Annual Congress 2007 - Current issues in airway physiology, pharmacology and monitoring Year: 2007 Nlrc5 is involved in allergic airway inflammation and negatively regulates inflammatory signaling pathway via TLR2/NF-?B. Source: International Congress 2018 – Translational models of the immunopathology that underlies airway obstructive diseases Year: 2018 Inhibition of uPA-uPAR signaling restores respiratory epithelial barrier function in asthma and COPD Source: International Congress 2019 – Cellular responses and cell therapy in lung injury and repair Year: 2019 Acrolein induces airway remodeling in mice via NF-κB pathway Source: Annual Congress 2009 - Preclinical models in drug development Year: 2009 Inhibition of ER stress suppresses IL-13 induced airway epithelial remodeling Source: International Congress 2019 – COPD, asthma and rhinitis: from cellular mechanisms to patients’ clinical responses Year: 2019 Role of IL-33 signaling in pollutant-induced allergic airway inflammation Source: International Congress 2018 – Translational models of the immunopathology that underlies airway obstructive diseases Year: 2018 Activation of TGFβ/Smad signalling pathway in induced sputum of asthmatic children Source: Annual Congress 2009 - Novel mechanisms in the pathogenesis of asthma Year: 2009 A role for WNT-5B in airway remodeling in COPD by activation of TGF-beta/Smad3 signaling? Source: Annual Congress 2013 –COPD: experimental biology Year: 2013 cPLA2alpha inhibitor ASB14780 suppresses airway MMP-9 production and improves respiratory function in cigarette-smoke induced model Source: International Congress 2014 – Animal models in respiratory drug development Year: 2014 Allergen avoidance improves allergic inflammation control through regulation of the AQP5-EGFR-mucin pathway Source: Annual Congress 2009 - Animal models of airways inflammation Year: 2009 Corticosteroids prevent airway remodeling in a mouse model of chronic asthma through TGF-β signaling Source: Eur Respir J 2006; 28: Suppl. 50, 225s Year: 2006 Effect of anti-IgE therapy on microRNAs in the lungs of mice with allergen-driven airway remodeling Source: Annual Congress 2012 - Molecular biology of pro- and anti-inflammatory responses in the lung Year: 2012 Rapamycin protects OVA induced asthma in mice through regulating autophagy Source: International Congress 2015 – Exploring mechanisms in obstructive airway diseases Year: 2015 Proto-oncogenes expression in airway remodelling in asthma Source: Eur Respir J 2001; 18: Suppl. 33, 159s Year: 2001 Bronchial vascular remodeling is attenuated by anti-IL17 in asthmatic responses exacerbated by LPS Source: International Congress 2019 – Modelling and monitoring of airway diseases Year: 2019 Low-level laser therapy effect on the bronchial hyperresponsiveness and the chronic allergy airway inflammation is driven to RhoA signaling and STAT-6 Source: Annual Congress 2013 –Murine models of lung immunology Year: 2013 4-1BBL/4-1BB costimulation alleviates airway inflammation by restoring Treg/Th17 balance in allergic asthma Source: Annual Congress 2012 - Asthma and COPD: understanding through mechanisms Year: 2012 Selective decoy-mediated inhibition of activator protein-1 activity in the airways prevents experimental asthmatic inflammation Source: Annual Congress 2005 - Regulation of the allergic and asthmatic response Year: 2005